Aktana’s Derek Choy joins leaders from Veeva, Salesforce, Antares and Monocl to break down how life sciences commercial teams are adapting to the digital shift accelerated by the pandemic. Read more from MM+M here
How will AI transform commercial life sciences in 2021? From a more agile approach to product launch to the decentralization of data science teams, Aktana’s Jim Anderson, Pini Ben-Or and Alan Kalton weigh in on the changes we can expect in the year ahead.
Understanding the “why” behind any recommendation is critical for adoption. In the December issue of Pharmaceutical-commerce, Derek Choy breaks down how explainable AI provides the context users need to trust AI and bring about true commercial transformation. Read the full article here.
We’re thrilled to be recognized with an Innovations Award from PM360 for our Contextual Intelligence Engine, which learns from every interaction to help sales, marketing and field medical teams coordinate more personalized, meaningful omnichannel engagements with HCPs. Established in 2011, the Annual PM360 Innovations Issue highlights the most exciting advancements that are helping to push […]
Industry leaders bolster engineering, technology and professional services for Aktana’s growing customer roster SAN FRANCISCO, CA Dec. 14, 2020 (GLOBE NEWSWIRE)–Today, Aktana,the pioneer in AI-driven intelligent engagement for the life sciences industry, announced major milestones of 2020, including key executive hires, expanded customer partnerships, and the launch of its next-generation Contextual Intelligence Engine. Aktana’s growth reflects […]
PharmaVOICE asked Derek Choy and other industry thought leaders how the role of AI in the life sciences will expand and evolve in 2021. Read their predictions for the new year here.
More information means more potential for personalization, but only if commercial teams can extract the right context to orchestrate meaningful HCP interactions at scale. Derek Choy tells PM360 how the next generation of AI tools have evolved to do just that. Read the full article here.
“AI 2.0 is here, and it’s helping companies deepen HCP engagement in a digitally driven commercial model.” Aktana’s co-founder and president, Derek Choy, explains how the next generation of AI uses context to create human experience in a digital-first world. Read the full article here.
Aktana was featured heavily in PharmaVOICE’s annual AI Showcase. Aktana’s GM of advanced services, Matthew Van Wingerden, shares 5 steps for successfully implementing an AI-driven omnichannel strategy. He was also interviewed on using AI effectively to solve the major challenges facing commercial life sciences today. Mike Weber, VP of product management, gave his take on […]
How can the next generation of life sciences AI better support the field, brand marketers and medical science liaisons? Aktana CEO David Ehrlich talks with Pharmaceutical Commerce about the blended approach that sets Contextual Intelligence apart. Read the full article here.